Patient Guide: A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 113 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04657289
Status: ACTIVE_NOT_RECRUITING
Condition: Neovascular Age-related Macular Degeneration (nAMD)
Phase: PHASE3

Where You Can Participate

This study is available at 113 locations across the country.

Top locations include:
  • • Capital Federal,
  • • Capital Federal,
  • • Rosario,
  • • And 110 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome) - Join Clinical Trial NCTNCT04657289

How to Join This Clinical Trial - NCTNCT04657289

Learn how to participate in this PHASE3 trial studying an investigational therapy for Neovascular Age-related Macular Degeneration (nAMD). Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Neovascular Age-related Macular Degeneration (nAMD). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Neovascular Age-related Macular Degeneration (nAMD)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04657289 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 113 locations. Find a study site near you:

Clinical Research Site

Capital Federal, C1116 - Argentina

Status: Contact for availability

Clinical Research Site

Capital Federal, C1120AAN - Argentina

Status: Contact for availability

Clinical Research Site

Rosario, S2000DLA - Argentina

Status: Contact for availability

Clinical Research Site

Albury, New South Wales 2640 - Australia

Status: Contact for availability

Clinical Research Site

Hurstville, New South Wales 2220 - Australia

Status: Contact for availability

Clinical Research Site

Liverpool, New South Wales 2170 - Australia

Status: Contact for availability

Clinical Research Site

Miranda, New South Wales 2228 - Australia

Status: Contact for availability

Clinical Research Site

Sydney, New South Wales 2000 - Australia

Status: Contact for availability

Clinical Research Site

Sydney, New South Wales 2000 - Australia

Status: Contact for availability

Clinical Research Site

Woolloongabba, Queensland 4102 - Australia

Status: Contact for availability

And 103 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Neovascular Age-related Macular Degeneration (nAMD):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships